Literature DB >> 10669628

Mouse model of femoral artery denudation injury associated with the rapid accumulation of adhesion molecules on the luminal surface and recruitment of neutrophils.

M Roque1, J T Fallon, J J Badimon, W X Zhang, M B Taubman, E D Reis.   

Abstract

Techniques of arterial injury commonly used in animals to mimic endovascular procedures are not suitable for small mouse arteries. This has limited examination of the response to arterial injury in genetically modified mice. We therefore sought to develop a model of transluminal injury to the mouse femoral artery that would be reproducible and result in substantial levels of intimal hyperplasia. Mice of the C57BL/6 strain underwent bilateral femoral artery denudation by passage of an angioplasty guidewire. Intimal hyperplasia was observed in 10% of injured arteries at 1 week, in 88% at 2 weeks, and in 90% at 4 weeks. The mean intimal-to-medial area ratio reached 1.1+/-0.1 at 4 weeks. No intimal proliferation was found in control sham-operated arteries. One hour after injury, the denuded surface was covered with platelets and leukocytes, predominantly neutrophils. This was associated with the accumulation of P-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1. Expression of these adhesion molecules was not seen in the underlying medial smooth muscle cells. At 24 hours, few neutrophils remained on the denuded surface. At 1 week, macrophages and platelets were present in the vessel wall, partially covered by regenerated endothelium. Transluminal wire injury to the mouse femoral artery induces abundant intimal hyperplasia formation by 2 and 4 weeks and elicits the rapid accumulation of leukocytes and adhesion molecules on the denuded luminal surface. This model will be a valuable tool to study arterial injury in genetically modified mouse models.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669628     DOI: 10.1161/01.atv.20.2.335

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  68 in total

1.  Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient mice.

Authors:  E D Reis; M Roque; H Dansky; J T Fallon; J J Badimon; C Cordon-Cardo; S J Shiff; E A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Sphingosine-1-phosphate receptor 3 promotes neointimal hyperplasia in mouse iliac-femoral arteries.

Authors:  Takuya Shimizu; Allison De Wispelaere; Martin Winkler; Travis D'Souza; Jacob Caylor; Lihua Chen; Frank Dastvan; Jessie Deou; Aesim Cho; Axel Larena-Avellaneda; Michael Reidy; Guenter Daum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-02-02       Impact factor: 8.311

3.  Ca2+/calmodulin-dependent protein kinase II-γ (CaMKIIγ) negatively regulates vascular smooth muscle cell proliferation and vascular remodeling.

Authors:  Fatima Z Saddouk; Li-Yan Sun; Yong Feng Liu; Miao Jiang; Diane V Singer; Johannes Backs; Dee Van Riper; Roman Ginnan; John J Schwarz; Harold A Singer
Journal:  FASEB J       Date:  2015-11-13       Impact factor: 5.191

4.  Specificity vs versatility: A fine balance for novel targeted molecular imaging radiotracers.

Authors:  James T Thackeray; Frank M Bengel
Journal:  J Nucl Cardiol       Date:  2016-02-10       Impact factor: 5.952

5.  CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.

Authors:  Guohong Li; John M Sanders; Melissa H Bevard; Zhiqi Sun; James W Chumley; Elena V Galkina; Klaus Ley; Ian J Sarembock
Journal:  Am J Pathol       Date:  2008-03-18       Impact factor: 4.307

6.  The intrinsic complement regulator decay-accelerating factor modulates the biological response to vascular injury.

Authors:  Masashi Sakuma; Toshifumi Morooka; Yunmei Wang; Can Shi; Kevin Croce; Huiyun Gao; Michael Strainic; M Edward Medof; Daniel I Simon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-03-18       Impact factor: 8.311

7.  Critical role for Syk in responses to vascular injury.

Authors:  Patrick Andre; Toshifumi Morooka; Derek Sim; Keith Abe; Clifford Lowell; Nisha Nanda; Suzanne Delaney; Gail Siu; Yibing Yan; Stan Hollenbach; Anjali Pandey; Huiyun Gao; Yunmei Wang; Kohsuke Nakajima; Sahil A Parikh; Can Shi; David Phillips; Whyte Owen; Uma Sinha; Daniel I Simon
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

8.  Human solCD39 inhibits injury-induced development of neointimal hyperplasia.

Authors:  J H F Drosopoulos; R Kraemer; H Shen; R K Upmacis; A J Marcus; E Musi
Journal:  Thromb Haemost       Date:  2009-12-18       Impact factor: 5.249

9.  Advanced glycation end product receptor-1 transgenic mice are resistant to inflammation, oxidative stress, and post-injury intimal hyperplasia.

Authors:  Massimo Torreggiani; Huixian Liu; Jin Wu; Feng Zheng; Weijing Cai; Gary Striker; Helen Vlassara
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

10.  Loss of the serum response factor cofactor, cysteine-rich protein 1, attenuates neointima formation in the mouse.

Authors:  Brenda Lilly; Kathleen A Clark; Masaaki Yoshigi; Stephen Pronovost; Meng-Ling Wu; Muthu Periasamy; Mei Chi; Richard J Paul; Shaw-Fang Yet; Mary C Beckerle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-07       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.